Alan Fuhrman

Affiliations

  • See Remarks at Checkmate Pharmaceuticals Inc. (CMPI), 2021-10-29
  • Director at Esperion Therapeutics Inc. (ESPR), 2021-05-28
  • Director at Springworks Therapeutics Inc. (SWTX), 2021-05-21
  • Director at Loxo Oncology Inc. (LOXO), 2019-02-15
  • Chief Financial Officer at Mirna Therapeutics Inc. (MIRN), 2016-03-14
  • Chief Financial Officer at Ambit Biosciences Corp (AMBI), 2014-11-12
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LOXO $178.07 2,625 Director 0 2018-06-08 Filing